Updated Jul 17, 2026

Selected portfolio

Top 1 · Quarterly · Equal

Rank #31

Risk

Experimental

Stocks included

Top 1

Rebalance

Quarterly

Weighting

Equal weight

Key metrics

Since Feb 17, 2026

  • Total return

    +17.1%
  • Performance vs S&P 500

    +8.1%
  • Sharpe ratio

    0.94
  • CAGR

    +46.7%
  • Max drawdown

    -26.4%

What you are looking at

Starting capital: $10,000 simulated. Disclaimer

#StockReturnOpen dateCurrent

Returns

Risk

Consistency

Want the methodology notes?

See the full methodology, portfolio-ranking rules, and scientific grounding.

Not investment advice. Past performance does not guarantee future results. Full disclaimer